Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

NCT05046262 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-09-16

No results posted yet for this study

Summary

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

Conditions

Interventions

DRUG

Calcium chloride

Calcium electroporation

Sponsors & Collaborators

  • Mirai Medical, Ireland

    collaborator UNKNOWN
  • Bispebjerg Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-08
Primary Completion
2022-02-22
Completion
2022-02-22

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05046262 on ClinicalTrials.gov